News and company development

PhenUtest has made rapid technological and corporate progress since it was spun out of the University of Liverpool in 2021.

2021

PhenUtest spun out of the University of Liverpool, known globally for its antimicrobial research.

Biological assay transition to microscopy funded by Innovate UK grant & University of Liverpool.

2 Patents filed in December 2021.

2022

Oversubscribed pre-seed funding round to refine biological protocol and start POC system development.

Ongoing relationships with two potential Fortune 500 commercial partners.

Hire of experienced CTO to lead POC system development. Rapid prototyping of several cartridge and chamber designs.

4 patent concepts developed in 2022.

Read on for our most recent development

PhenUtest Shortlisted for BioNow Start-Up Award 2023

Bath, UK, February 6 2024

Experienced medtech executive becomes CEO at Phenutest Diagnostics

Bath, UK, January 31 2023

This test has not been approved or cleared by the U.S. Food and Drug Administration.
The performance characteristics of this test have not been established.

Biosciences Building, Crown Street
Liverpool, L69 7BE, UK

info@phenutest.com

Biosciences Building, Crown Street
Liverpool, L69 7BE, UK

info@phenutest.com